William Michael Cox, MD in Nome, AK - Radiology

William Michael Cox, MD is a Radiology - Diagnostic Radiology physician based in Nome, Alaska. William Michael Cox is licensed to practice in Alaska (license number 2136) and his current practice location is 306 West 5th Ave, Nome, Alaska. He can be reached at his office (for appointments etc.) via phone at (907) 443-3311.

NPI number for William Michael Cox is 1255302014 and his current mailing address is Po Box 966, Nome, Alaska. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1255302014.

Contact Information

	William Michael Cox, MD
	306 West 5th Ave, Nome, AK 99762-0966
	(907) 443-3311
	(907) 443-3139

Physician's Profile

Full Name	William Michael Cox
Gender	Male
Speciality	Radiology - Diagnostic Radiology
Location	306 West 5th Ave, Nome, Alaska
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1255302014
Provider Enumeration Date: 01/30/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for William Michael Cox such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255302014	NPI	-	NPPES
682925	Medicaid	AK

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2085R0202X	Radiology - Diagnostic Radiology	2136 (Alaska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. William Michael Cox is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
William Michael Cox, MD Po Box 966, Nome, AK 99762-0966 Ph: (907) 443-3311	William Michael Cox, MD 306 West 5th Ave, Nome, AK 99762-0966 Ph: (907) 443-3311

News Archive

New injection device delivers optimum treatment dose to hepatitis C patients

A new injection device, ViraferonPeg Clearclick, has launched in the UK today for hepatitis C patients to accurately titrate and self-administer their weekly dose of ViraferonPeg (peginterferon alfa-2b).

Boehringer Ingelheim announces FDA approval of Praxbind (idarucizumab)

Boehringer Ingelheim Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration granted approval of Praxbind (idarucizumab). PRAXBIND is indicated for patients treated with Pradaxa (dabigatran etexilate mesylate), when reversal of the anticoagulant effects of dabigatran is needed for emergency surgery/urgent procedures or in life-threatening or uncontrolled bleeding.

New clinical trial to test safety and efficacy of antibody cocktail against COVID-19

In a new clinical trial, UC Davis Health will test the effectiveness and safety of REGN-COV2, the monoclonal antibody cocktail, in preventing COVID-19 in adults living with infected patients.

Five new genetic mutations linked with Crohn's disease in Ashkenazi Jews

In the largest study of its kind, researchers from Mount Sinai School of Medicine have discovered five new genetic mutations associated with Crohn's disease in Jews of Eastern European descent, also known as Ashkenazi Jews.

Survey results show significant positive impact on quality of care from use of PDAs in pediatric practice

Survey results released today in time for the American Academy of Pediatrics 2004 National Conference & Exhibition show significant positive impact on quality of care from use of PDAs in pediatric practice.

William Michael Cox, MD - Radiology in Nome, AK